Nanomedicine News

RSS

New Investment for Development of CNSE’s RNA Technology by Hocus Locus

Governor Andrew M. Cuomo today announced that the RNA technology invented at CNSE will be developed by Albany-based Hocus Locus, LLC with a recent investment from Eastern New York Angels. Once developed, the technology will provide medical researchers and healthcare providers with a new diagnostic tool to aid in the detection of cancer and other diseases. Its creators say the technology could also lead to the development of new treatments for those diseases.

From College of Nanoscale Science and Engineering, University at Albany 10 Oct 2013

Development of Nanoparticle Technology-Based Mucosal Vaccines Receives SEK 16 Million Funding

The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines.

9 Oct 2013

NanoViricides Initiates Non-GLP Toxicology Evaluation of Optimized Injectable FluCide

NanoViricides, Inc., reports that it has initiated the initial non-GLP toxicology evaluation of its optimized injectable FluCide® drug candidate. This study is an important step in the drug development pathway for FluCide.

9 Oct 2013

Genisphere Enhances 3DNA Nanotechnology for Universal Signal Amplification System Applications

Genisphere LLC reported today it has adapted its 3DNA® Nanotechnology for use as a universal signal amplification system for improving the sensitivity and overall performance of rapid diagnostic tests and applications.

8 Oct 2013

Novavax Begins Enrollment in RSV Vaccine Phase 2 Dose-Confirmatory Clinical Trial

Novavax, Inc. today announced that enrollment has begun in a Phase 2 dose-confirmatory clinical trial of its respiratory syncytial virus (RSV) vaccine candidate in women of childbearing age.

From Novavax Inc. 8 Oct 2013

Mammalian Cells Prefer Disc-Shaped Rather Than Rod-Shaped Nanoparticles

For years scientists have been working to fundamentally understand how nanoparticles move throughout the human body. One big unanswered question is how the shape of nanoparticles affects their entry into cells. Now researchers have discovered that under typical culture conditions, mammalian cells prefer disc-shaped nanoparticles over those shaped like rods.

From Georgia Institute of Technology 8 Oct 2013

Tekmira Presents Additional TKM-PLK1 Data at 6th Annual NET Conference

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today announced that it presented additional TKM-PLK1 data at the 6th Annual NET Conference hosted by the North American Neuroendocrine Tumor Society (NA-NETS) to be held in Charleston, South Carolina from October 4-5, 2013.

5 Oct 2013

NIH Grant to Develop New Nanotechnology for Better Cancer Treatment

UB researcher Jonathan Lovell has received a five-year, $1.9 million grant from the National Institutes of Health to work on a new nanotechnology that could greatly improve how doctors treat and understand cancer.

5 Oct 2013

MultiCell Technologies Inks New Sponsored Research Agreement for Liver Cancer Treatment

MultiCell Technologies, Inc. is pleased to announce the signing of a new sponsored research agreement with Anand Ghanekar, M.D., Ph.D, of the University Health Network's Toronto General Hospital expanding the scope of the research project to evaluate MCT-485 in animal models for the treatment of primary liver cancer.

4 Oct 2013

New Project to Determine Heart Attack and Stroke Risk Using Nanoparticles

A Temple bioengineer is collaborating on an NIH-funded project to develop a nanotechnology that will help doctors determine the location and severity of plaques in artery walls before they rupture.

4 Oct 2013

Nanomedicine News

New Investment for Development of CNSE’s RNA Technology by Hocus Locus

Development of Nanoparticle Technology-Based Mucosal Vaccines Receives SEK 16 Million Funding

NanoViricides Initiates Non-GLP Toxicology Evaluation of Optimized Injectable FluCide

Genisphere Enhances 3DNA Nanotechnology for Universal Signal Amplification System Applications

Novavax Begins Enrollment in RSV Vaccine Phase 2 Dose-Confirmatory Clinical Trial

Mammalian Cells Prefer Disc-Shaped Rather Than Rod-Shaped Nanoparticles

Tekmira Presents Additional TKM-PLK1 Data at 6th Annual NET Conference

NIH Grant to Develop New Nanotechnology for Better Cancer Treatment

MultiCell Technologies Inks New Sponsored Research Agreement for Liver Cancer Treatment

New Project to Determine Heart Attack and Stroke Risk Using Nanoparticles

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Sustainable Future for Carbon Nanotubes

Sustainable ZnO Nanoparticles for Methylene Blue Cleanup

Enhancing Material Properties through Nanotube Encapsulation

Modeling the Growth of Hexagonal Boron Nitride for Next-Generation Applications

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials